The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

16 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
New 5H-pyridazino[4,5-b]indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics.EBI
Universidad De Navarra
Novel sulfonylurea derivatives as H3 receptor antagonists. Preliminary SAR studies.EBI
Universidad De Navarra
Novel antagonists of 5-HT3 receptors. Synthesis and biological evaluation of piperazinylquinoxaline derivatives.EBI
Universidad De Navarra
Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.EBI
Universidad De Navarra
Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.EBI
Universidad De Navarra
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review.EBI
Universidad De Navarra
Examination of multiple Trypanosoma cruzi targets in a new drug discovery approach for Chagas disease.EBI
Universidad De Navarra
Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists.EBI
Universidad De Navarra
Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.EBI
Universidad De Navarra
In Vitro and in Vivo Anti-Trypanosoma cruzi Activity of New Arylamine Mannich Base-Type Derivatives.EBI
Universidad De Navarra
New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.EBI
Universidad De Navarra
Rational modification of Mannich base-type derivatives as novel antichagasic compounds: Synthesis, in vitro and in vivo evaluation.EBI
Universidad De Navarra
Development and Therapeutic Potential of Selenazo Compounds.EBI
Universidad De Navarra
Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.EBI
Universidad De Navarra
Phenotypic Screening To Discover Novel Chemical Series as Efficient Antihemorrhagic Agents.EBI
Universidad De Navarra
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.BDB
The Johns Hopkins University